We utilized the Gene Set Cancer Analysis (GSCA) online platform [30] to discover that ZNF92 expression is uniquely associated with sensitivity to the 90-kDa heat shock protein (Hsp90) inhibitor Tanespimycin (17-AAG), a synthetic analog of the antibiotic Geldanamycin [33]. The gene discussed is HSP90AB1; the disease is cancer.